Bendamustine/polatuzumab-vedotin/rituximabVarious toxicities and compassionate use: 7 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1927卷 / 1期

关键词：

D O I：

10.1007/s40278-022-24866-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：130 / 130

相关论文

共 50 条

[31] Bendamustine/rituximabVarious toxicities: case report
[J]. Reactions Weekly, 2018, 1686 (1) : 77 - 77
[32] CemiplimabVarious toxicities following compassionate use: 7 case reports
[J]. Reactions Weekly, 2021, 1881 (1) : 70 - 70
[33] Abatacept/corticosteroids/rituximabVarious toxicities: 7 case reports
[J]. Reactions Weekly, 2021, 1852 (1) : 15 - 15
[34] Bendamustine/brentuximab-vedotin/nivolumab/vinblastineVarious toxicities: 9 case reports
[J]. Reactions Weekly, 2020, 1799 (1) : 94 - 94
[35] RituximabVarious toxicities: 4 case reports
[J]. Reactions Weekly, 2020, 1795 (1) : 242 - 242
[36] RituximabVarious toxicities: 6 case reports
[J]. Reactions Weekly, 2014, 1503 (1) : 39 - 39
[37] RituximabVarious toxicities: 3 case reports
[J]. Reactions Weekly, 2013, 1457 (1) : 34 - 34
[38] RituximabVarious toxicities: 2 case reports
[J]. Reactions Weekly, 2017, 1663 (1) : 266 - 266
[39] RituximabVarious toxicities: 3 case reports
[J]. Reactions Weekly, 2022, 1927 (1) : 469 - 469
[40] RituximabVarious toxicities: 15 case reports
[J]. Reactions Weekly, 2018, 1694 (1) : 382 - 382

← 1 2 3 4 5 →